See more : ACON S2 Acquisition Corp. (STWOU) Income Statement Analysis – Financial Results
Complete financial analysis of Evolus, Inc. (0K16.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Evolus, Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Defense Technologies International Corp. (DTII) Income Statement Analysis – Financial Results
- Catalyst Pharmaceuticals, Inc. (CPRX) Income Statement Analysis – Financial Results
- Prairie Provident Resources Inc. (PPR.TO) Income Statement Analysis – Financial Results
- Sundram Fasteners Limited (SUNDRMFAST.NS) Income Statement Analysis – Financial Results
- Ofuna Technology Co., Ltd. (4577.TWO) Income Statement Analysis – Financial Results
Evolus, Inc. (0K16.L)
About Evolus, Inc.
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 202.09M | 148.62M | 99.67M | 56.54M | 34.93M | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 61.56M | 55.89M | 43.53M | 18.30M | 8.01M | 9.00K | 218.00K | 326.00K | 416.00K |
| Gross Profit | 140.53M | 92.73M | 56.14M | 38.24M | 26.91M | -9.00K | -218.00K | -326.00K | -416.00K |
| Gross Profit Ratio | 69.54% | 62.40% | 56.32% | 67.64% | 77.05% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 6.56M | 4.74M | 2.06M | 1.72M | 3.97M | 6.49M | 6.69M | 12.61M | 20.68M |
| General & Administrative | 157.45M | 130.20M | 0.00 | 0.00 | 0.00 | 29.15M | 4.82M | 7.03M | 9.88M |
| Selling & Marketing | 7.49M | 11.64M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 164.94M | 141.84M | 112.07M | 98.19M | 113.59M | 29.15M | 4.82M | 7.03M | 9.88M |
| Other Expenses | 18.26M | 3.72M | 5.62M | 7.03M | 4.13M | -10.50M | -5.00K | -6.00K | -39.00K |
| Operating Expenses | 189.76M | 150.30M | 119.75M | 106.94M | 121.70M | 35.64M | 11.73M | 19.97M | 30.98M |
| Cost & Expenses | 251.32M | 206.19M | 163.29M | 125.24M | 129.71M | 35.64M | 11.73M | 19.97M | 30.98M |
| Interest Income | 860.00K | 119.00K | 1.00K | 635.00K | 1.84M | 203.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 13.83M | 9.10M | 1.40M | 10.50M | 7.95M | 863.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 5.87M | 4.50M | 6.31M | 7.68M | 5.01M | 9.00K | 218.00K | 326.00K | 416.00K |
| EBITDA | -41.81M | -60.72M | -39.06M | -144.75M | -92.10M | -46.13M | -11.51M | -19.64M | -30.56M |
| EBITDA Ratio | -20.69% | -40.03% | -64.49% | -104.40% | -266.22% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -49.23M | -57.58M | -63.62M | -68.70M | -94.79M | -46.14M | -11.73M | -19.97M | -30.98M |
| Operating Income Ratio | -24.36% | -38.74% | -63.82% | -121.50% | -271.40% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -12.28M | -8.99M | -2.36M | -9.87M | -6.11M | -660.00K | -5.00K | -6.00K | -39.00K |
| Income Before Tax | -61.51M | -74.32M | -46.77M | -162.94M | -105.06M | -46.80M | -11.73M | -19.97M | -31.02M |
| Income Before Tax Ratio | -30.44% | -50.01% | -46.92% | -288.18% | -300.82% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 176.00K | 95.00K | 42.00K | 77.00K | -15.03M | 65.00K | -7.25M | 93.00K | 93.00K |
| Net Income | -61.69M | -74.41M | -46.81M | -163.01M | -90.03M | -46.87M | -4.48M | -20.07M | -31.11M |
| Net Income Ratio | -30.52% | -50.07% | -46.96% | -288.31% | -257.79% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -1.08 | -1.33 | -0.94 | -4.83 | -3.19 | -1.92 | -0.19 | -1.08 | -1.67 |
| EPS Diluted | -1.08 | -1.33 | -0.94 | -4.83 | -3.19 | -1.92 | -0.19 | -1.08 | -1.67 |
| Weighted Avg Shares Out | 56.92M | 56.07M | 49.77M | 33.74M | 28.24M | 24.40M | 23.59M | 18.59M | 18.59M |
| Weighted Avg Shares Out (Dil) | 56.92M | 56.07M | 49.77M | 33.74M | 28.24M | 24.40M | 23.59M | 18.59M | 18.59M |
Source: https://incomestatements.info
Category: Stock Reports